Dolby Laboratories
(DLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 231,619 | 255,505 | 42,305 | 207,106 | 186,402 |
| Depreciation Amortization | 112,684 | 85,481 | 83,756 | 87,066 | 88,976 |
| Income taxes - deferred | -5,274 | -40,191 | 61,059 | -35,046 | -22,798 |
| Accounts receivable | 1,251 | -27,492 | 100,129 | -56,559 | 24,886 |
| Other Working Capital | -100,417 | -61,176 | 83,850 | 49,514 | 37,703 |
| Other Operating Activity | 103,986 | 115,547 | -18,897 | 125,712 | 44,895 |
| Operating Cash Flow | $343,849 | $327,674 | $352,202 | $377,793 | $360,064 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66,347 | -96,281 | -72,814 | -99,617 | -100,762 |
| Net Acquisitions | N/A | -14,919 | -22,852 | N/A | N/A |
| Purchase Of Investment | -287,777 | -265,361 | -174,195 | -289,530 | -426,118 |
| Sale Of Investment | 491,138 | 337,587 | 360,490 | 236,371 | 366,112 |
| Purchase Sale Intangibles | -2,640 | -17,255 | -12,543 | -5,250 | -121,020 |
| Other Investing Activity | -2,640 | -17,255 | -12,543 | -5,250 | -121,729 |
| Investing Cash Flow | $134,374 | $-56,229 | $78,086 | $-158,026 | $-282,497 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 82,658 | 57,346 | 106,162 | 69,998 | 71,111 |
| Common Stock Repurchased | -173,742 | -340,585 | -150,470 | -100,000 | -100,854 |
| Dividend Paid | -88,581 | -77,496 | -66,155 | -57,059 | -48,397 |
| Other Financing Activity | -28,110 | -24,546 | -23,166 | -19,770 | -13,846 |
| Financing Cash Flow | $-207,775 | $-385,281 | $-133,629 | $-106,831 | $-91,986 |
| Exchange Rate Effect | 3,938 | -5,821 | -5,777 | 1,675 | -1,395 |
| Beginning Cash Position | 805,593 | 925,250 | 634,368 | 519,757 | 531,926 |
| End Cash Position | 1,079,979 | 805,593 | 925,250 | 634,368 | 516,112 |
| Net Cash Flow | $274,386 | $-119,657 | $290,882 | $114,611 | $-15,814 |
| Free Cash Flow | |||||
| Operating Cash Flow | 343,849 | 327,674 | 352,202 | 377,793 | 360,064 |
| Capital Expenditure | -66,347 | -96,281 | -72,814 | -99,617 | -100,762 |
| Free Cash Flow | 277,502 | 231,393 | 279,388 | 278,176 | 259,302 |